Cargando…

Analytical variation in factor VIII one‐stage and chromogenic assays: Experiences from the ECAT external quality assessment programme

BACKGROUND: Both one‐stage (OSA) and chromogenic substrate assays (CSA) are used to measure factor VIII (FVIII) activity. Factors explaining analytical variation in FVIII activity levels are still to be completely elucidated. AIM: The aim of this study was to investigate and quantify the analytical...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Moort, Iris, Meijer, Piet, Priem‐Visser, Debby, van Gammeren, Adriaan J., Péquériaux, Nathalie C. V., Leebeek, Frank W. G., Cnossen, Marjon H., de Maat, Moniek P. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916413/ https://www.ncbi.nlm.nih.gov/pubmed/30488994 http://dx.doi.org/10.1111/hae.13643

Ejemplares similares

The one‐stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non‐severe haemophilia A: Superiority or non‐inferiority?
por: Schütte, Lisette M., et al.
Publicado: (2020)

Impact of extreme weight loss on factor VIII concentrate pharmacokinetics in haemophilia
por: van Moort, Iris, et al.
Publicado: (2021)

Does difference between label and actual potency of factor VIII concentrate affect pharmacokinetic‐guided dosing of replacement therapy in haemophilia A?
por: Goedhart, Tine M.H.J., et al.
Publicado: (2022)

Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients
por: van Moort, Iris, et al.
Publicado: (2020)

Performance of factor IX extended half‐life product measurements in external quality control assessment programs
por: Nederlof, Angelique, et al.
Publicado: (2020)

Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding
por: Atiq, Ferdows, et al.
Publicado: (2021)

eCAT: Online electronic lab notebook for scientific research
por: Goddard, Nigel H, et al.
Publicado: (2009)

Tailoring the effect of antithrombin-targeting therapy in haemophilia A using in silico thrombin generation
por: de Laat-Kremers, Romy M. W., et al.
Publicado: (2021)

Validation of a perioperative population factor VIII pharmacokinetic model with a large cohort of pediatric hemophilia a patients
por: Preijers, Tim, et al.
Publicado: (2021)

Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease
por: Boender, Johan, et al.
Publicado: (2021)

ECAT1 is essential for human oocyte maturation and pre-implantation development of the resulting embryos
por: Liu, Changyu, et al.
Publicado: (2016)

Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab
por: Lee, Min Young, et al.
Publicado: (2023)

In silico comparison of pharmacokinetic properties of three extended half-life factor IX concentrates
por: Preijers, Tim, et al.
Publicado: (2021)

Current and Emerging Options for the Management of Inherited von Willebrand Disease
por: Heijdra, Jessica M., et al.
Publicado: (2017)

ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020)

Association between Sports Participation, Factor VIII Levels and Bleeding in Hemophilia A
por: Bukkems, Laura H., et al.
Publicado: (2022)

Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients
por: Swinkels, Maurice, et al.
Publicado: (2022)

ProxECAT: Proxy External Controls Association Test. A new case-control gene region association test using allele frequencies from public controls
por: Hendricks, Audrey E., et al.
Publicado: (2018)

Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study
por: Schütte, Lisette M, et al.
Publicado: (2019)

Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age‐related increase of VWF in von Willebrand disease
por: Atiq, Ferdows, et al.
Publicado: (2018)

Identification and targeted disruption of the mouse gene encoding ESG1 (PH34/ECAT2/DPPA5)
por: Amano, Hisayuki, et al.
Publicado: (2006)

Relationship between factor VIII levels and bleeding for rFVIII‐SingleChain in severe hemophilia A: A repeated time‐to‐event analysis
por: Bukkems, Laura H., et al.
Publicado: (2023)

ECAT11/L1td1 Is Enriched in ESCs and Rapidly Activated During iPSCGeneration, but It Is Dispensable for the Maintenance and Induction of Pluripotency
por: Iwabuchi, Kumiko A., et al.
Publicado: (2011)

The ECAT dataset: expert-validated distribution data of endemic and sub-endemic trees of Central Africa (Dem. Rep. Congo, Rwanda, Burundi)
por: Tack, Wesley, et al.
Publicado: (2022)

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic‐pharmacodynamic model for patients with haemophilia A
por: Bukkems, Laura H., et al.
Publicado: (2022)

Desmopressin testing in von Willebrand disease: Lowering the burden
por: Heijdra, Jessica M., et al.
Publicado: (2022)

Assessing the Performance of Extended Half-Life Coagulation Factor VIII, FC Fusion Protein by Using Chromogenic and One-Stage Assays in Saudi Hemophilia A Patients
por: Owaidah, Tarek M., et al.
Publicado: (2020)

Performance Related Factors Are the Main Determinants of the von Willebrand Factor Response to Exhaustive Physical Exercise
por: van Loon, Janine E., et al.
Publicado: (2014)

Usefulness of Chromogenic Media with Fluconazole Supplementation for Presumptive Identification of Candida auris
por: Ruiz-Gaitán, Alba, et al.
Publicado: (2023)

Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia
por: Preijers, Tim, et al.
Publicado: (2020)

Chromogenic and Fluorogenic Probes for the Detection of Illicit Drugs
por: Garrido, Eva, et al.
Publicado: (2018)

Functionalized Quinoxaline for Chromogenic and Fluorogenic Anion Sensing
por: Dey, Sandeep Kumar, et al.
Publicado: (2018)

Fusion proteins with chromogenic and keratin binding modules
por: Tinoco, Ana, et al.
Publicado: (2019)

Novel Derivatives of Nitrobenzofurazan with Chromogenic and Fluorogenic Properties
por: Bujor, Alexandru, et al.
Publicado: (2023)

Long-term impact of joint bleeds in von Willebrand disease: a nested case-control study
por: van Galen, Karin P.M., et al.
Publicado: (2017)

Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking
por: Ebberink, Eduard H.T.M., et al.
Publicado: (2017)

Spectral Imaging of Multi-Color Chromogenic Dyes in Pathological Specimens
por: Macville, Merryn V. E., et al.
Publicado: (2001)

Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype
por: Kempers, Eva K., et al.
Publicado: (2021)

Effect of Genetic Variation in STXBP5 and STX2 on von Willebrand Factor and Bleeding Phenotype in Type 1 von Willebrand Disease Patients
por: van Loon, Janine E., et al.
Publicado: (2012)

BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease
por: Atiq, Ferdows, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qjd8pkguorec3iqmlbh0ri22it